• Gliclazide Tablets, Tablet, Drug, Pharmaceutical
  • Gliclazide Tablets, Tablet, Drug, Pharmaceutical
  • Gliclazide Tablets, Tablet, Drug, Pharmaceutical
  • Gliclazide Tablets, Tablet, Drug, Pharmaceutical
  • Gliclazide Tablets, Tablet, Drug, Pharmaceutical

Gliclazide Tablets, Tablet, Drug, Pharmaceutical

Application: Oral Preparation
Usage Mode: For oral administration
Suitable for: Elderly, Children, Adult
State: Solid
Shape: Tablet
Type: Organic Chemicals
Customization:
Gold Member Since 2018

Suppliers with verified business licenses

Manufacturer/Factory

Basic Info.

Model NO.
80mg*60
Pharmaceutical Technology
Chemical Synthesis
Drug Reg./Approval No.
Guoyaozhunzih13021831
Package
300boxes/Carton
Carton Size
410*350*310
Transport Package
Carton
Specification
80mg*60
Trademark
SHIMEN
Origin
Hebei
HS Code
3004909099
Production Capacity
5000000000

Product Description

Product Description

Gliclazide Tablets

Quick Details

Product Name: Gliclazide Tablets
Strength: 80mg*60
Payment term: TT, LC
Intercom: FOB, CIF
MOQ:10,000 box
Price:Please send enquiry


THERAPY AREA: Oral Preparation

Shijiazhuang No.4- China exporter, global supplier & GMP manufacturer of Gliclazide Tablets


The main ingredient of this product is Gliclazide.

Chemical name: 1-(3-azabicyclo[3.3.0]octyl)-3-p-toluenesulfonylurea.

Chemical Structure:
Gliclazide Tablets, Tablet, Drug, Pharmaceutical

Molecular formula: C15H21N3O3S

Molecular weight: 323.41

Properties
This product is a white tablet.
Indications
For type 2 diabetes.
[Specification] No permission
Dosage
Orally, the initial dosage is 40-80 mg, 1-2 times a day, and then adjusted to 80-240 mg a day according to the blood sugar level, and taken in 2-3 times. After the blood sugar is controlled, the daily maintenance dose is changed. Elderly patients are reduced.
Adverse reactions
Occasionally mild nausea, vomiting, epigastric pain, constipation, diarrhea, erythema, urticaria, thrombocytopenia, granulocytopenia, anemia, etc., most of which disappeared after stopping the drug.
Taboo
It is contraindicated for those with liver and kidney insufficiency.
Those who are allergic to sulfonylureas are forbidden.

Not for use in people with type 1 diabetes.

When combined with anticoagulant drugs, blood coagulation tests should be done regularly.

When the dose of this product is too large, eating too little or exercising vigorously, attention should be paid to prevent hypoglycemia.

It should be taken under the guidance of a physician. Must regularly check the patient's blood sugar, urine sugar.


[drug overdose]
still uncertain.

[Storage] Sealed and stored in a dry place.
[Packaging] Aluminum-plastic blister pack, 20 tablets/board, 3 board/box

manufacturer:
Enterprise Name: Shijiazhuang No.4 Pharmaceutical Co., Ltd.
Production address: Yangzi Road, Shijiazhuang Economic and Technological Development Zone
Gliclazide Tablets, Tablet, Drug, Pharmaceutical

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now